FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023196856> ?p ?o ?g. }

• W3023196856 endingPage "960" @default.
• W3023196856 startingPage "953" @default.
• W3023196856 abstract "To investigate the impact of direct-acting antivirals (DAAs) and 12-week sustained virologic response (SVR12) in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) treated by interventional oncology (IO) therapies.Retrospective analysis of patients diagnosed from 2005 to 2016 with HCC and receiving IO therapies. A total of 478 patients met inclusion criteria. Patients were age 29-90 years (mean 63.6 ± 9.4 years) and 78.9% (n =3 77) male. Two hundred and eighty-five (57%) patients had chronic HCV, 93 (33%) received DAAs, and 63 (68%) achieved SVR12. Liver function, tumor characteristics, and IO therapy including ablation, image-guided transcatheter tumor therapies (ITTT) (eg, chemoembolization and radioembolization), and combination locoregional therapy were assessed in analysis.Median overall survival (OS) of the cohort was 26.7 months (95% confidence interval [CI] 21.9-29.9). OS for ablation, combination locoregional therapy and ITTT, was 37.3 (CI 30.7-49.9), 29.3 (CI 24.2-38.0), and 19.7 months (CI 16.5-22.8), respectively (P < .0001). OS in patients with HCV was 30.7 months (CI 24.2-35.2) versus 22.2 months in non-HCV patients (CI 17.8-27.8, P = .03). Patients with HCV who received DAA had higher survival, 49.2 months (CI 36.5-not reached) versus those not receiving DAA, 18.5 months (CI 14.1-25.3, P < .0001). OS was 71.8 months (CI 42.3-not reached) for patients who achieved SVR12 after DAA versus 26.7 months in the non-SVR12 group (CI 15.9-31.1, P < .0001). Multivariable analysis revealed independent factors for OS including IO treatment type, DAA use and achieving SVR12 (P < .05).DAA use and SVR12 is associated with higher OS in patients with HCV-related HCC treated by IO therapies." @default.
• W3023196856 created "2020-05-13" @default.
• W3023196856 creator A5008472753 @default.
• W3023196856 creator A5012787104 @default.
• W3023196856 creator A5049834093 @default.
• W3023196856 creator A5054537619 @default.
• W3023196856 creator A5062652107 @default.
• W3023196856 date "2020-06-01" @default.
• W3023196856 modified "2023-10-17" @default.
• W3023196856 title "Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma" @default.
• W3023196856 cites W1497045310 @default.
• W3023196856 cites W1530007295 @default.
• W3023196856 cites W1989005528 @default.
• W3023196856 cites W2021199098 @default.
• W3023196856 cites W2024763248 @default.
• W3023196856 cites W2027545702 @default.
• W3023196856 cites W2068043937 @default.
• W3023196856 cites W2072712324 @default.
• W3023196856 cites W2074454470 @default.
• W3023196856 cites W2104010560 @default.
• W3023196856 cites W2107713887 @default.
• W3023196856 cites W2127685726 @default.
• W3023196856 cites W2137901368 @default.
• W3023196856 cites W2145814334 @default.
• W3023196856 cites W2164439784 @default.
• W3023196856 cites W2213448039 @default.
• W3023196856 cites W2507707536 @default.
• W3023196856 cites W2550102850 @default.
• W3023196856 cites W2552432336 @default.
• W3023196856 cites W2559460526 @default.
• W3023196856 cites W2583985389 @default.
• W3023196856 cites W2593387920 @default.
• W3023196856 cites W2657055765 @default.
• W3023196856 cites W2741420622 @default.
• W3023196856 cites W2742558906 @default.
• W3023196856 cites W2748400966 @default.
• W3023196856 cites W2752705079 @default.
• W3023196856 cites W2796067155 @default.
• W3023196856 cites W2801964940 @default.
• W3023196856 cites W2809701302 @default.
• W3023196856 cites W2893023854 @default.
• W3023196856 cites W2895913658 @default.
• W3023196856 cites W2896821475 @default.
• W3023196856 cites W2897658568 @default.
• W3023196856 cites W2898378712 @default.
• W3023196856 cites W2903855001 @default.
• W3023196856 cites W2928271725 @default.
• W3023196856 cites W971519378 @default.
• W3023196856 doi "https://doi.org/10.1016/j.jvir.2019.12.809" @default.
• W3023196856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32376182" @default.
• W3023196856 hasPublicationYear "2020" @default.
• W3023196856 type Work @default.
• W3023196856 sameAs 3023196856 @default.
• W3023196856 citedByCount "5" @default.
• W3023196856 countsByYear W30231968562021 @default.
• W3023196856 countsByYear W30231968562022 @default.
• W3023196856 countsByYear W30231968562023 @default.
• W3023196856 crossrefType "journal-article" @default.
• W3023196856 hasAuthorship W3023196856A5008472753 @default.
• W3023196856 hasAuthorship W3023196856A5012787104 @default.
• W3023196856 hasAuthorship W3023196856A5049834093 @default.
• W3023196856 hasAuthorship W3023196856A5054537619 @default.
• W3023196856 hasAuthorship W3023196856A5062652107 @default.
• W3023196856 hasBestOaLocation W30231968561 @default.
• W3023196856 hasConcept C126322002 @default.
• W3023196856 hasConcept C141071460 @default.
• W3023196856 hasConcept C167135981 @default.
• W3023196856 hasConcept C203014093 @default.
• W3023196856 hasConcept C2522874641 @default.
• W3023196856 hasConcept C2776408679 @default.
• W3023196856 hasConcept C2776455275 @default.
• W3023196856 hasConcept C2776999253 @default.
• W3023196856 hasConcept C2778019345 @default.
• W3023196856 hasConcept C2992208098 @default.
• W3023196856 hasConcept C44249647 @default.
• W3023196856 hasConcept C71924100 @default.
• W3023196856 hasConcept C72563966 @default.
• W3023196856 hasConcept C90924648 @default.
• W3023196856 hasConceptScore W3023196856C126322002 @default.
• W3023196856 hasConceptScore W3023196856C141071460 @default.
• W3023196856 hasConceptScore W3023196856C167135981 @default.
• W3023196856 hasConceptScore W3023196856C203014093 @default.
• W3023196856 hasConceptScore W3023196856C2522874641 @default.
• W3023196856 hasConceptScore W3023196856C2776408679 @default.
• W3023196856 hasConceptScore W3023196856C2776455275 @default.
• W3023196856 hasConceptScore W3023196856C2776999253 @default.
• W3023196856 hasConceptScore W3023196856C2778019345 @default.
• W3023196856 hasConceptScore W3023196856C2992208098 @default.
• W3023196856 hasConceptScore W3023196856C44249647 @default.
• W3023196856 hasConceptScore W3023196856C71924100 @default.
• W3023196856 hasConceptScore W3023196856C72563966 @default.
• W3023196856 hasConceptScore W3023196856C90924648 @default.
• W3023196856 hasFunder F4320306078 @default.
• W3023196856 hasFunder F4320314513 @default.
• W3023196856 hasFunder F4320332501 @default.
• W3023196856 hasIssue "6" @default.
• W3023196856 hasLocation W30231968561 @default.
• W3023196856 hasLocation W30231968562 @default.

• next